ArticleMolecular medicine (Cambridge, Mass.)2022

Kinome profiling of cholangiocarcinoma organoids reveals potential druggable targets that hold promise for treatment stratification.

Ruby Lieshout et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.